Verona Pharma plc (I9SA) — Cash Flow Quality Index

Latest as of June 2025: 2.56x

Verona Pharma plc (I9SA) has a Cash Flow Quality Index of 2.56x as of June 2025. Operating cash flow of €30.56 Million exceeds net income of €11.92 Million, indicating high earnings quality where cash backs reported profits. Explore I9SA long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

2.56x

Operating CF / Net Income

Operating Cash Flow

€30.56 Million

EUR

Net Income

€11.92 Million

EUR

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Verona Pharma plc (None–None)

Year-by-year earnings quality comparison for Verona Pharma plc. For live market cap and the full company financial profile, see I9SA company net worth.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.